 MALVERN, Pa., Nov. 08, 2021 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health Services Forum, 12th Annual Jefferies London Healthcare Conference, and the 33rd Annual Piper Sandler Healthcare Conference. 